Venrock Adviser, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Venrock Adviser, Llc disclosed 31 stock positions valued at approximately $3.30B as of quarter-end June 30, 2026. The largest holdings include APOGEE THERAPEUTICS INC, ORUKA THERAPEUTICS INC, and ERASCA INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 31
- Portfolio Value
- $3.30B
Holdings by Sector
Venrock Adviser, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC | APGE | Healthcare | 34.18% | 8,493,321 | - | - | $1,127,318,496 |
| ORUKA THERAPEUTICS INC | ORKA | Other | 11.97% | 4,148,428 | - | - | $394,805,893 |
| ERASCA INC | ERAS | Healthcare | 9.94% | 17,891,812 | +1,509,000 | +9.21% | $327,777,996 |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 8.04% | 2,985,448 | -700,000 | -18.99% | $265,048,073 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 3.49% | 1,180,000 | - | - | $115,026,400 |
| OCULAR THERAPEUTIX INC | OCUL | Healthcare | 3.08% | 10,346,926 | - | - | $101,606,813 |
| SAVARA INC | SVRA | Healthcare | 2.75% | 14,745,943 | +1,005,568 | +7.32% | $90,835,009 |
| JADE BIOSCIENCES INC | JBIO | Other | 2.17% | 3,220,364 | - | - | $71,556,488 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 1.93% | 1,642,166 | -357,834 | -17.89% | $63,551,824 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 1.81% | 3,257,917 | -624,792 | -16.09% | $59,847,935 |
| VOR BIOPHARMA INC | VOR | Other | 1.70% | 3,041,719 | - | - | $55,998,047 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.46% | 2,173,913 | - | - | $48,282,608 |
| MAZE THERAPEUTICS INC | MAZE | Other | 1.45% | 1,602,034 | - | - | $47,804,695 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 1.44% | 6,844,305 | +2,000,925 | +41.31% | $47,362,591 |
| ORIC PHARMACEUTICALS INC | ORIC | Healthcare | 1.42% | 4,319,765 | - | - | $46,783,055 |
| ZURA BIO LTD | ZURA | Other | 1.15% | 6,434,990 | - | - | $37,966,441 |
| ADLAI NORTYE LTD | ANL | Other | 1.12% | 3,212,731 | - | - | $36,946,407 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 0.81% | 526,331 | -1,200,000 | -69.51% | $26,711,298 |
| CYBIN INC | HELP | Other | 0.77% | 3,851,654 | - | - | $25,459,433 |
| CULLINAN THERAPEUTICS INC | CGEM | Healthcare | 0.76% | 1,379,965 | - | - | $25,129,163 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 0.65% | 8,695,652 | - | - | $21,304,347 |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | Other | 0.60% | 2,043,596 | +434,027 | +26.97% | $19,822,881 |
| CYTOMX THERAPEUTICS INC | CTMX | Healthcare | 0.57% | 4,982,124 | -5,000,000 | -50.09% | $18,682,965 |
| ACHIEVE LIFE SCIENCE INC | ACHV | Healthcare | 0.54% | 2,751,032 | +2,751,032 | +100.00% | $17,964,239 |
| PARABILIS MEDICINES INC | PBLS | Other | 0.52% | 625,000 | +625,000 | +100.00% | $17,106,250 |
| SURROZEN INC | SRZN | Healthcare | 0.50% | 632,931 | - | - | $16,424,559 |
| KORRO BIO INC | KRRO | Healthcare | 0.40% | 1,009,500 | - | - | $13,305,210 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 0.40% | 500,000 | - | - | $13,195,000 |
| X4 PHARMACEUTICALS INC | XFOR | Other | 0.27% | 1,934,253 | +1,603,728 | +485.21% | $9,032,962 |
| RESEARCH ALLIANCE CORP III | RACC | Other | 0.10% | 300,000 | +300,000 | +100.00% | $3,210,000 |
Showing 30 of 31 holdings in the latest reporting period.